|
FDA To Keep Publishing MOUs in FR, Concerns Raised About Transparency
A letter from device and diagnostic company Cook Group appears to be behind the FDA’s decision to withdraw a final rule on transparency of agency memoranda of understanding (MOUs).
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives